Location History:
- Hyogo, JP (2014)
- Osaka, JP (2019)
Company Filing History:
3 out of 229 
1 out of 1,285 
1 out of 417 
Years Active: 2014-2025
Title: Chiho Yabuta: Innovator in Retinal and Corneal Health
Introduction
Chiho Yabuta is a notable inventor based in Osaka, Japan. He has made significant contributions to the fields of ophthalmology and retinal health. With a total of 3 patents, Yabuta's work focuses on innovative solutions for preventing and treating eye disorders.
Latest Patents
Yabuta's latest patents include a retinal ganglion cell death inhibitor. This invention relates to a suppressor that comprises a BMPR signal transduction inhibitor. It aims to protect retinal neurons and offers a pharmaceutical composition for preventing or treating diseases involving retinal ganglion cell death, such as glaucoma, diabetic retinopathy, and retinal vascular occlusion. Another significant patent is an agent for the prevention or treatment of corneal disorders. This invention targets conditions such as corneal epithelial disorder, dry eye, and reduction in corneal sensitivity, utilizing angiopoietin-like protein 7 as an active ingredient.
Career Highlights
Throughout his career, Chiho Yabuta has worked with prominent organizations, including Senju Pharmaceutical Co., Ltd. and The University of Tokyo. His experience in these institutions has allowed him to develop groundbreaking inventions that address critical health issues.
Collaborations
Yabuta has collaborated with notable colleagues, including Tomohiko Usui and Fumiko Yano. Their combined expertise has contributed to the advancement of research in eye health.
Conclusion
Chiho Yabuta's innovative work in retinal and corneal health showcases his dedication to improving patient outcomes. His patents reflect a commitment to addressing significant medical challenges in ophthalmology.